
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
frizzled-7 CRISPR/Cas9 KO Plasmid (m) | sc-420437 | 20 µg | $397.00 |
Mouse Fzd7 encodes frizzled-7, a seven-transmembrane Wnt receptor that transduces extracellular Wnt ligands into intracellular signaling outputs. Frizzled-7 regulates β-catenin–dependent transcriptional programs as well as non-canonical planar cell polarity and Wnt/Ca²⁺ pathways, shaping proliferation, polarity, migration, and fate decisions during development and tissue homeostasis. Altered Fzd7 signaling has been linked to dysregulated stem/progenitor cell behavior and oncogenic pathway activation in multiple experimental models, making it a useful entry point for dissecting Wnt network control. In cell systems, Fzd7 perturbation is commonly used to interrogate receptor-level Wnt signaling specificity and crosstalk with receptor tyrosine kinase and Hippo/YAP-associated processes.
frizzled-7 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Fzd7 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Fzd7 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Fzd7 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish frizzled-7 protein expression.
This CRISPR knockout system enables efficient generation of Fzd7-deficient cell models for investigation of frizzled-7 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.